use of at least one compound, peptide, and pharmaceutical formulation

• 收藏
• 分享

专利权人:

Affiris AG

发明人:

Edith Kopinits,Harald Weninger,Markus Mandler,Radmila Santic

申请号：

BRPI0915136

公开号：

BRPI0915136A2

申请日:

2009.06.12

申请国别(地区):

BR

年份:

2019

代理人:

摘要：

The present invention relates to the use of mimotopes in the treatment of &bgr；-Amyloidoses including but not limited to Alzheimer's disease, whereby said mimotopes are able to induce the in vivo formation of antibodies directed to non truncated A&bgr；1-40/42, and N-terminally truncated forms A&bgr；pE3-40/42, A&bgr；3-40/42, A&bgr；11-40/42, A&bgr；pE11-40/42 and A&bgr；14-40/42 without interfering with physiological functions of APP signalling.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/